Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Copper continues to rally on manufacturer optimism

July 22, 2010 1:45 pm | by TALI ARBEL - AP Business Writer - Associated Press | News | Comments

Copper prices continued to rally Thursday, hitting a two-month high as big U.S. manufacturers say they're optimistic about the economy.In other active trading, an extreme Russian drought supported wheat prices, which have rallied about 25 percent this month. Prices touched a 13-month...

Neurocrine Biosciences Announces Conference Call and Webcast to Report Second Quarter 2010 Financial Results

July 22, 2010 11:36 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO , July 22 /- Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) announced today that the Company will report its second quarter 2010 financial results after the Nasdaq market closes on Wednesday, July 28, 2010 .  Neurocrine will then host a  live conference call and webcast...

TOPICS:

MedInformatix RIS Improves 60-Year-Old Radiology Business' Cash Flow and Accounts Receivable, Speeding Accounts Receivable on Full Breadth of Imaging Procedures

July 22, 2010 11:36 am | by Bio-Medicine.Org | News | Comments

LOS ANGELES , July 22 /- Upon its founding more than 60 years ago, Robert D. Russo M.D . and Associates Radiology's business and model was infinitely more simple than what technology, the nation's economy and medical insurance practices have conspired to make the six-location Fairfield...

TOPICS:
Advertisement

Lotus Pharmaceuticals Terminates SEDA

July 22, 2010 11:36 am | by Bio-Medicine.Org | News | Comments

BEIJING , July 22 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a growing developer, manufacturer and seller of medicine and drugs in the People's Republic of China (the "PRC"), announced today that it has entered into a...

TOPICS:

Joyful Slim Herb Supplement : Recall-Undeclared Drug Ingredient

July 22, 2010 11:30 am | by U.S. Food & Drug Administration | News | Comments

Product contains sibutramine; may increase blood pressure/pulse rate with risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, stroke.

TOPICS:

Recovery mixed on strong earnings, weak home sales

July 22, 2010 9:45 am | by ALAN ZIBEL - AP Business Writers - Associated Press | News | Comments

A flurry of strong earnings reports renewed Wall Street's optimism in the economic recovery, even as new data Thursday showed homes sales sinking and claims for unemployment benefits rising.Sales of previously occupied homes fell 5.1 percent in June to a seasonally adjusted annual rate of 5.37...

Oil prices rise on stormy forecast for Gulf

July 22, 2010 8:45 am | by SANDY SHORE - AP Business Writer - Associated Press | News | Comments

Oil prices advanced Thursday as energy producers kept an eye on a developing tropical storm that could move into the Gulf of Mexico by the weekend.At the gas pump, prices were unchanged at a national average of $2.718 for a gallon of unleaded regular gasoline, according to AAA, Wright Express and...

Golden Meditech Announces Annual Results for FY 2009/10

July 22, 2010 8:34 am | by Bio-Medicine.Org | News | Comments

HONG KONG , July 22 /PRNewswire-Asia-FirstCall/ -- China's leading integrated medical enterprise Golden Meditech Holdings Limited ("Golden Meditech" or the "Group," HKEx: 801) is pleased to announce its annual results for the year ended 31 March 2010 . During the reporting period, total...

TOPICS:
Advertisement

Huifeng Bio-Pharmaceutical Technology Announces a New Spain Order

July 22, 2010 8:34 am | by Bio-Medicine.Org | News | Comments

XI'AN, China , July 22 /PRNewswire-Asia-FirstCall/ -- Huifeng Bio-Pharmaceutical Technology, Inc. (OTC Bulletin Board: HFGB), specializing in developing and producing botanical extracts and other raw materials for pharmaceuticals and food additives, today announced the receipt of its...

TOPICS:

CardioGenics Holdings Inc. Receives New Ticker Symbol

July 22, 2010 8:33 am | by Bio-Medicine.Org | News | Comments

MISSISSAUGA, Ontario , July 22 /- CardioGenics Holdings Inc. (OTC Bulletin Board: CGNH), developer of the ultra-sensitive QL Care™ Point-Of-Care (POC) analyzer and products for the immunoassay segment of the In-Vitro Diagnostics market, announced that the Company's ticker symbol has...

TOPICS:

Sysmex America and Medica Corporation Announce Distribution Partnership

July 22, 2010 8:33 am | by Bio-Medicine.Org | News | Comments

MUNDELEIN, Ill. , July 22 /- Sysmex America, Inc., a leading developer and manufacturer of medical diagnostic instrumentation and information systems, today announced a partnership agreement with Medica Corporation for the exclusive distribution of the EasyCell® assistant to...

TOPICS:

US earnings, European growth hopes lift stocks

July 22, 2010 6:45 am | by PAN PYLAS - AP Business Writer - Associated Press | News | Comments

World stock markets brushed aside a downbeat assessment of the U.S. outlook from Federal Reserve chairman Ben Bernanke and posted solid gains Thursday on the back of strong economic and corporate news.In Europe, the FTSE 100 index of leading British shares was up 67.31 points, or 1.3 percent,...

Birmingham selects Health Portal to deliver on NHS White Paper data sharing imperatives

July 22, 2010 6:37 am | by RealWire | News | Comments

Dotted Eyes Health Portal enables Birmingham Health and Wellbeing Partnership to more cost effectively share data with GPs and across all partnerships to deliver on new healthcare reformsBirmingham, England, 22 July 2010 - Dotted Eyes, data and information specialists to the UK public...

TOPICS:

Startup Euthymics lands in Cambridge with $24M funding

July 22, 2010 6:37 am | by Mass High Tech: The Journal of New England Technology | News | Comments

A merger and a $24 million Series A funding has landed life sciences startup Euthymics Bioscience Inc. in Cambridge.

TOPICS:

Novelos nabs $1.5M through private equities sale

July 22, 2010 6:34 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Novelos Therapeutics Inc. reports it has raised $1.5 million through a private placement of stock and warrants to fund the company through the second quarter of 2011, and move its breast cancer and hepatitis drug candidates forward.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading